As of close of business last night, Biosig Technologies Inc’s stock clocked out at $1.51, up 37.27% from its previous closing price of $1.10. On the day, 3274968 shares were traded.
Ratios:
To gain a deeper understanding of BSGM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.27.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on March 30, 2020, initiated with a Buy rating and assigned the stock a target price of $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 13 ’23 when LONDONER KENNETH L bought 15,600 shares for $1.24 per share. The transaction valued at 19,358 led to the insider holds 2,507,020 shares of the business.
LONDONER KENNETH L bought 6,000 shares of BSGM for $7,040 on Jun 12 ’23. The Chief Executive Officer now owns 2,491,420 shares after completing the transaction at $1.17 per share. On Jun 02 ’23, another insider, LONDONER KENNETH L, who serves as the Chief Executive Officer of the company, bought 4,600 shares for $1.37 each. As a result, the insider paid 6,292 and bolstered with 2,485,420 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 100.63.
Stock Price History:
Over the past 52 weeks, BSGM has reached a high of $16.50, while it has fallen to a 52-week low of $0.26.
Shares Statistics:
A total of 9.33M shares are outstanding, with a floating share count of 7.74M. Insiders hold about 17.06% of the company’s shares, while institutions hold 11.37% stake in the company.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.5 for the current quarter, with a high estimate of -$0.5 and a low estimate of -$0.5, while EPS last year was -$1.42. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$3.7 and -$3.7 for the fiscal current year, implying an average EPS of -$3.7. EPS for the following year is -$1.5, with 1 analysts recommending between -$1.5 and -$1.5.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for BSGM’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $100k. In the same quarter a year ago, actual revenue was $254k, down -60.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M. The average revenue growth estimate for next year is up 1,400.00% from the average revenue estimate for this year.
